Proteo: New member of advisory board will strengthen company development

18-May-2006

Proteo, Inc. and its wholly-owned subsidiary Proteo Biotech AG announced, that Proteo Biotech AG has appointed Dr. Jürgen Paal, Manager Strategic Projects at Altana Pharma AG in Constance, Germany, as a member of its advisory board.

Dr. Paal will extend the board into the sector of company development. Preclinical and clinical expertise are represented on the advisory board by Professor Jens-Michael Schröder (Coordinator of the Collaborative Research Center SFB 617 at the University of Kiel) and Professor Fred Fändrich (Chairman of the Dept. of General and Thoracic Surgery, University of Kiel).

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances